指南与共识血脂与心血管预防心律失常瓣膜病与结构性心脏病

不明来源栓塞性卒中的综合血栓栓塞风险评估:ESC卒中委员会等临床共识

Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.
指南 / 共识 · Eur Heart J · 2024-01-01

每6例缺血性卒中中约1例为不明来源栓塞性卒中(ESUS),其总体心血管风险高。本共识由ESC卒中委员会、欧洲心血管影像协会和欧洲心律协会的多学科专家组制定,提出不应推测单一栓塞来源,而应综合评估所有并存病理相关的个体风险,以优化二级预防。

要点

  • ESUS患者常存在多种潜在血栓栓塞来源并存,单一病因推测不可靠。
  • 应综合评估所有已识别病理(无论是否推测因果相关)的个体风险,形成总体血栓栓塞风险。
  • 针对 presumed 单一来源的特异性治疗可能低估其他病理的血栓栓塞潜力,需多维度评估。

核心结论

  • ESUS患者总体心血管风险高,应通过综合所有并存病理相关的个体风险来评估总体血栓栓塞风险,而非推测单一栓塞来源。

研究设计与样本

  • 欧洲心脏病学会卒中委员会、欧洲心血管影像协会和欧洲心律协会联合制定的临床共识声明,由多学科专家组(心脏病学、内科、神经病学、放射学和血管外科)撰写。

主要发现

  • 每6例缺血性卒中患者中约1例为ESUS,即尽管经过推荐诊断评估仍病因不明。
  • ESUS患者中多种潜在血栓栓塞来源常同时存在,使病因判断具有挑战性。
  • 针对推测的单一病理进行特异性治疗后,患者仍可能因其他已识别但血栓栓塞潜力被低估的病理而发生卒中和心血管事件。

关键数值与推荐

  • ESUS定义为尽管经过推荐诊断评估仍病因不明的卒中。
  • 推荐通过综合所有现存病理(无论是否推测因果相关)相关的个体风险来评估总体血栓栓塞风险。

临床怎么用

  • 临床面对ESUS患者时,应全面评估所有已识别病理的血栓栓塞风险,而非仅针对推测的单一栓塞来源进行治疗。
  • 二级预防策略应基于总体血栓栓塞风险的综合评估,以优化预防复发性卒中和其他心血管事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS), defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The overall cardiovascular risk of ESUS is high and it is important to optimize strategies to prevent recurrent stroke and other cardiovascular events. The aim of clinicians when confronted with a patient not only with ESUS but also with any other medical condition of unclear aetiology is to identify the actual cause amongst a list of potential differential diagnoses, in order to optimize secondary prevention. However, specifically in ESUS, this may be challenging as multiple potential thromboembolic sources frequently coexist. Also, it can be delusively reassuring because despite the implementation of specific treatments for the individual pathology presumed to be the actual thromboembolic source, patients can still be vulnerable to stroke and other cardiovascular events caused by other pathologies already identified during the index diagnostic evaluation but whose thromboembolic potential was underestimated. Therefore, rather than trying to presume which particular mechanism is the actual embolic source in an ESUS patient, it is important to assess the overall thromboembolic risk of the patient through synthesis of the individual risks linked to all pathologies present, regardless if presumed causally associated or not. In this paper, a multi-disciplinary panel of clinicians/researchers from various backgrounds of expertise and specialties (cardiology, internal medicine, neurology, radiology and vascular surgery) proposes a comprehensive multi-dimensional assessment of the overall thromboembolic risk in ESUS patients through the composition of individual risks associated with all prevalent pathologies.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Ntaios G, Baumgartner H, Doehner W, et al. Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC. Eur Heart J. 2024. PMID: 38685132. doi:10.1093/eurheartj/ehae150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。